Open-label study to evaluate the pharmacodynamics, clinical efficacy, and safety of meropenem for adult bacterial meningitis in Japan

Journal of Infection and Chemotherapy

Volumn 20, Issue 9, 2014, Pages 535-540

  Morita, Akihiko ^a   Kamei, Satoshi ^a   Minami, Masayuki ^a   Yoshida, Kazuto ^b   Kawabata, Satoshi ^b   Kuroda, Hiroshi ^c   Suzuki, Yasushi ^d   Araki, Nobuo ^e   Iwasaki, Yasuo ^f   Kobayashi, Rei ^g   Hayashi, Naoki ^g   Hirayama, Tetsuyuki ^g   Ochiai, Jun ^h   Ueda, Miki ^h   Yamagishi, Yuka ⁱ   Niwa, Jun Ichi ⁱ   Shindo, Katsuro ^j   Fukushima, Yoshihisa ^k   Takita, Tomohiro ^l   Sato, Takayuki ^m   Sato, Shigeru ⁿ   Mikamo, Hiroshige ^o   Iwata, Satoshi ^p   more..

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ASAHIKAWA RED CROSS HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

^d SENDAI CITY MEDICAL CENTER   (Japan)

^e SAITAMA MEDICAL UNIVERSITY HOSPITAL   (Japan)

^f TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^h Nagoya Ekisaikai Hospital   (Japan)

ⁱ AICHI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^j KURASHIKI CENTRAL HOSPITAL   (Japan)

^k ST MARY S HOSPITAL   (Japan)

^l NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^m DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

ⁿ KOHNAN HOSPITAL   (Japan)

^o AICHI MEDICAL UNIVERSITY   (Japan)

^p KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Adult; Bacterial meningitis; Efficacy; Japanese; Meropenem; Safety

Indexed keywords

MEROPENEM; ANTIINFECTIVE AGENT; THIENAMYCIN DERIVATIVE;

ADULT; ARTICLE; BACTERIAL MENINGITIS; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; INJECTION SITE INFLAMMATION; JAPANESE (PEOPLE); LIVER DYSFUNCTION; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; NAUSEA; RASH; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS SALIVARIUS; THRUSH; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; AGED; CEREBROSPINAL FLUID; CLINICAL TRIAL; DRUG EFFECTS; FEMALE; JAPAN; MALE; MENINGITIS, BACTERIAL; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTICENTER STUDY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; TREATMENT OUTCOME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; JAPAN; MALE; MENINGITIS, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; THIENAMYCINS; TREATMENT OUTCOME;

EID: 84906306432     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2014.04.013     Document Type: Article

References (16)

1. M.C. Thigpen, C.G. Whitney, N.E. Messonnier, E.R. Zell, R. Lynfield, and J.L. Hadler et al. Bacterial meningitis in the United States, 1998-2007 N Engl J Med 364 2011 2016 2025
2. D. van de Beek, J. de Gans, L. Spanjaard, M. Weisfelt, J.B. Reitsma, and M. Vermeulen Clinical features and prognostic factors in adults with bacterial meningitis N Engl J Med 351 2004 1849 1859
3. M. Ishihara, S. Kamei, N. Taira, A. Morita, K. Miki, and T. Naganuma et al. Hospital-based study of the prognostic factors in adult patients with acute community-acquired bacterial meningitis in Tokyo, Japan Intern Med 48 2009 295 300
4. K. Ubukata, N. Chiba, M. Morozumi, S. Iwata, and K. Sunakawa Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000-2011 J Infect Chemother 19 2013 34 41
5. N. Begg, K.A. Cartwright, J. Cohen, E.B. Kaczmarski, J.A. Innes, and C.L. Leen et al. Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party J Infect 39 1999 1 15
6. A. Chaudhuri, P. Martinez-Martin, P.E. Kennedy, R. Andrew Seaton, P. Portegies, and M. Bojar et al. EFNS task force. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS task force on acute bacterial meningitis in older children and adults Eur J Neurol 15 2008 649 659
7. A.R. Tunkel, B.J. Hartman, S.L. Kaplan, B.A. Kaufman, K.L. Roos, and W.M. Scheld et al. Practice guidelines for the management of bacterial meningitis Clin Infect Dis 39 2004 1267 1284
8. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement vol. 33 2013 M100 M123 Wayne, Pennsylvania
9. K.P. Klugman, and R. Dagan Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group Antimicrob Agents Chemother 39 1995 1140 1146
10. C.M. Odio, J.R. Puig, J.M. Feris, W.N. Khan, W.J. Rodriguez, and G.H. McCracken Jr. et al. Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group Pediatr Infect Dis J 18 1999 581 590
11. E. Schmutzhard, K.J. Williams, G. Vukmirovits, V. Chmelik, B. Pfausler, and A. Featherstone A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group J Antimicrob Chemother 36 Suppl. A 1995 85 97
12. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement vol. 27 2007 M100 M117 Wayne, Pennsylvania
13. Japanese Society of Neurological Therapeutics The Japanese guideline of medical examination and treatment for bacterial meningitis Shinkei Chiryo-gaku (Neurol Therap) 24 2007 69 132
14. R. Dagan, L. Velghe, J.L. Rodda, and K.P. Klugman Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges J Antimicrob Chemother 34 1994 175 179
15. I. Lutsar, G.J. McCracken, and I.R. Friedland Antibiotic pharmacodynamics in cerebrospinal fluid Clin Infect Dis 27 1998 1117 1127
16. K. Yamaguchi, Y. Ishii, M. Iwata, N. Watanabe, M. Shinagawa, and M. Yasujima et al. Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2009 Jpn J Antibiot 64 2011 53 95